Aurora Cannabis (ACB) Tax Provisions (2017 - 2026)
Aurora Cannabis (ACB) posted quarterly Tax Provisions of -$538000.0 for Q1 2026, down 116.38% year-on-year from $3.3 million in Q1 2025, and down 654.64% on a QoQ basis from $97000.0 in Q4 2025.
Aurora Cannabis (ACB) Tax Provisions (2017 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Tax Provisions for 10 consecutive years, with -$538000.0 the latest figure, recorded in Q1 2026.
- Quarterly Tax Provisions fell 116.38% year-over-year to -$538000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$709645.2 (down 144.32% YoY) and the FY2026 annual result came in at $1.5 million, down 50.36% from the prior year.
- Tax Provisions declined to -$538000.0 in Q1 2026 per ACB's latest filing, from $97000.0 in the prior quarter.
- Over the last five years, Tax Provisions for ACB reached as high as $54.0 million in Q3 2023 and fell as low as -$49.0 million in Q2 2023.
- A 5-year average of $67280.0 and a median of -$360712.5 in 2025 frame the typical range for Tax Provisions.
- The largest YoY upside for Tax Provisions was 2480.92% in 2023 against a maximum downside of 14869.0% in 2023.
- Year by year, Tax Provisions stood at -$1.9 million in 2022, then surged by 96.55% to -$67000.0 in 2023, then slumped by 462.69% to -$377000.0 in 2024, then surged by 125.73% to $97000.0 in 2025, then plunged by 654.64% to -$538000.0 in 2026.
- According to Business Quant data, Tax Provisions over the past three periods registered -$538000.0, $97000.0, and -$344425.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 67.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 157.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 676.90 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 43.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -423.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 48.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 30.00 Mn |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn | -538,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -538,000.00 |
| Dec 31, 2025 | 97,000.00 |
| Sep 30, 2025 | -344,424.99 |
| Jun 30, 2025 | 75,779.81 |
| Mar 31, 2025 | 3.29 Mn |
| Dec 31, 2024 | -377,000.00 |
| Sep 30, 2024 | -706,663.49 |
| Jun 30, 2024 | -600,266.39 |
| Mar 31, 2024 | -711,000.00 |
| Dec 31, 2023 | -67,000.00 |
| Sep 30, 2023 | 54.00 Mn |
| Jun 30, 2023 | -49.00 Mn |
| Dec 31, 2022 | -1.94 Mn |
| Sep 30, 2022 | -2.27 Mn |
| Jun 30, 2022 | 331,776.10 |
| Mar 31, 2022 | -159,474.03 |
| Dec 31, 2021 | -65,053.56 |
| Sep 30, 2021 | -137,432.81 |
| Jun 30, 2021 | -8.11 Mn |
| Mar 31, 2021 | 7,900.99 |